T1	Participants 58 99	women with locally advanced breast cancer
T2	Participants 248 275	patients with breast cancer
T3	Participants 484 614	Patients were recruited for this open-label, phase 2 randomised trial between March 17, 2003, and May 19, 2006, at a single centre
T4	Participants 832 865	120 women were randomly assigned,
